These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

626 related items for PubMed ID: 26409788

  • 1. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
    Katsuyama T, Otsuka F, Terasaka T, Inagaki K, Takano-Narazaki M, Matsumoto Y, Sada KE, Makino H.
    Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788
    [Abstract] [Full Text] [Related]

  • 2. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, Miyoshi T, Goto J, Yamamura M, Makino H.
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M, Otsuka F, Matsumoto Y, Inagaki K, Takeda M, Nakamura E, Tsukamoto N, Miyoshi T, Sada KE, Makino H.
    Mol Cell Endocrinol; 2012 Jan 02; 348(1):224-32. PubMed ID: 21888945
    [Abstract] [Full Text] [Related]

  • 4. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
    Matsumoto Y, Otsuka F, Takano M, Mukai T, Yamanaka R, Takeda M, Miyoshi T, Inagaki K, Sada KE, Makino H.
    Mol Cell Endocrinol; 2010 Aug 30; 325(1-2):118-27. PubMed ID: 20638987
    [Abstract] [Full Text] [Related]

  • 5. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling.
    Mukai T, Otsuka F, Otani H, Yamashita M, Takasugi K, Inagaki K, Yamamura M, Makino H.
    Biochem Biophys Res Commun; 2007 May 18; 356(4):1004-10. PubMed ID: 17397798
    [Abstract] [Full Text] [Related]

  • 6. Sprouty2 is involved in the control of osteoblast proliferation and differentiation through the FGF and BMP signaling pathways.
    Taketomi T, Onimura T, Yoshiga D, Muratsu D, Sanui T, Fukuda T, Kusukawa J, Nakamura S.
    Cell Biol Int; 2018 Sep 18; 42(9):1106-1114. PubMed ID: 28921936
    [Abstract] [Full Text] [Related]

  • 7. Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation.
    Sato C, Iwasaki T, Kitano S, Tsunemi S, Sano H.
    Biochem Biophys Res Commun; 2012 Jun 22; 423(1):200-5. PubMed ID: 22659743
    [Abstract] [Full Text] [Related]

  • 8. Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation.
    Huang RL, Yuan Y, Tu J, Zou GM, Li Q.
    Cell Death Dis; 2014 Apr 17; 5(4):e1187. PubMed ID: 24743742
    [Abstract] [Full Text] [Related]

  • 9. Acetyl-11-Keto-β-Boswellic Acid Promotes Osteoblast Differentiation by Inhibiting Tumor Necrosis Factor-α and Nuclear Factor-κB Activity.
    Bai F, Chen X, Yang H, Xu HG.
    J Craniofac Surg; 2018 Oct 17; 29(7):1996-2002. PubMed ID: 29927820
    [Abstract] [Full Text] [Related]

  • 10. Relaxin augments BMP-2-induced osteoblast differentiation and bone formation.
    Moon JS, Kim SH, Oh SH, Jeong YW, Kang JH, Park JC, Son HJ, Bae S, Park BI, Kim MS, Koh JT, Ko HM.
    J Bone Miner Res; 2014 Jul 17; 29(7):1586-96. PubMed ID: 24643989
    [Abstract] [Full Text] [Related]

  • 11. NEMO-binding domain peptide promotes osteoblast differentiation impaired by tumor necrosis factor alpha.
    Li W, Yu B, Li M, Sun D, Hu Y, Zhao M, Cui CB, Hou S.
    Biochem Biophys Res Commun; 2010 Jan 08; 391(2):1228-33. PubMed ID: 20006586
    [Abstract] [Full Text] [Related]

  • 12. Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-alpha in human bone cells.
    Singhatanadgit W, Salih V, Olsen I.
    Int J Biochem Cell Biol; 2006 Jan 08; 38(10):1794-807. PubMed ID: 16797218
    [Abstract] [Full Text] [Related]

  • 13. Functional relationship between fibroblast growth factor-8 and bone morphogenetic proteins in regulating steroidogenesis by rat granulosa cells.
    Miyoshi T, Otsuka F, Yamashita M, Inagaki K, Nakamura E, Tsukamoto N, Takeda M, Suzuki J, Makino H.
    Mol Cell Endocrinol; 2010 Aug 30; 325(1-2):84-92. PubMed ID: 20434519
    [Abstract] [Full Text] [Related]

  • 14. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
    Phimphilai M, Zhao Z, Boules H, Roca H, Franceschi RT.
    J Bone Miner Res; 2006 Apr 30; 21(4):637-46. PubMed ID: 16598384
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD.
    Bone; 2008 Apr 30; 42(4):669-80. PubMed ID: 18294945
    [Abstract] [Full Text] [Related]

  • 20. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
    Yonezawa T, Lee JW, Hibino A, Asai M, Hojo H, Cha BY, Teruya T, Nagai K, Chung UI, Yagasaki K, Woo JT.
    Biochem Biophys Res Commun; 2011 Jun 03; 409(2):260-5. PubMed ID: 21570953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.